Myopathies featuring early or prominent dysphagia.
James D TriplettMarcus Vinicius PintoEmily A HosfieldMargherita MiloneTeerin LiewluckPublished in: Muscle & nerve (2020)
IBM and IMNM accounted for approximately two-thirds of patients with early or prominent dysphagia at our institution. Rapidly progressive dysphagia may predict immunotherapy responsiveness.
Keyphrases